Skip to main content
TipRanks
Go Ultimate75% OFF

ArriVent BioPharma, Inc. (AVBP) Balance Sheet

101 Followers

ArriVent BioPharma, Inc. Balance Sheet

ArriVent BioPharma, Inc.'s total assets for Q3 2026 were $417.09M, an increase of 5.67% from the previous quarter. AVBP total liabilities were $23.61M for the fiscal quarter, a 15.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 333.17M$ 274.94M$ 163.10M$ 182.83M$ 43.04M
$ 25.95M$ 17.29M$ 11.80M$ 8.37M$ 1.82M
$ 307.22M$ 257.65M$ 151.30M$ 174.46M$ 41.22M

Currency in USD

ArriVent BioPharma, Inc. Liabilities to Assets

0120M240M360M4 %6 %8 %10 %LiabilitiesLiabilities to Assets20212022202320242025AssetsLiabilitiesLiabilities to Assets